Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] AREA[ConditionSearch] Anemia
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 … 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 Next Last
#
NCTID/Status
Study
Last Changed
1001
NCT02497924
Completed
Completed
A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects
Conditions: Anemia, Sickle Cell
Intervention: GBT440
Conditions: Anemia, Sickle Cell
Intervention: GBT440
April 10, 2017
1002
NCT00559195
Completed
Completed
Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors
Conditions: Anemia; Fatigue; Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Epoetin Beta, Quality-of-life Assessment
Conditions: Anemia; Fatigue; Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Epoetin Beta, Quality-of-life Assessment
May 13, 2011
1003
NCT02411708
Completed
Completed
Study of SANGUINATE™ In the Treatment of Sickle Cell Disease Patients With Vaso-Occlusive Crisis
Conditions: Anemia, Sickle Cell
Intervention: SANGUINATE, Placebo
Conditions: Anemia, Sickle Cell
Intervention: SANGUINATE, Placebo
May 22, 2018
1004
NCT02394587
Completed
Completed
MBSR for Pain Catastrophizing in SCD
Conditions: Anemia, Sickle Cell
Intervention: Mindfulness-based Stress Reduction
Conditions: Anemia, Sickle Cell
Intervention: Mindfulness-based Stress Reduction
December 27, 2017
1005
NCT02445144
Active, not recruiting
Active, not recruiting
Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease
Conditions: Sickle Cell Anemia
Conditions: Sickle Cell Anemia
January 8, 2019
1006
NCT00236678
Terminated
Terminated
Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT
Conditions: Anemia; Rheumatoid Arthritis
Intervention: Epoetin Alfa
Conditions: Anemia; Rheumatoid Arthritis
Intervention: Epoetin Alfa
June 8, 2011
1007
NCT03610230
Recruiting
Recruiting
Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients
Conditions: Iron Deficiency Anemia Treatment
Intervention: Iron Isomaltoside, Iron Sucrose
Conditions: Iron Deficiency Anemia Treatment
Intervention: Iron Isomaltoside, Iron Sucrose
April 30, 2019
1008
NCT03528434
Recruiting
Recruiting
Zinc for Infection Prevention in Sickle Cell Anemia (ZIPS)
Conditions: Sickle Cell Disease
Intervention: Zinc, Placebo
Conditions: Sickle Cell Disease
Intervention: Zinc, Placebo
June 12, 2019
1009
NCT00004485
Completed
Completed
Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
Conditions: Sickle Cell Anemia
Intervention: Cyclosporine, Fludarabine, Mycophenolate Mofetil, Bone Marrow Transplantation
Conditions: Sickle Cell Anemia
Intervention: Cyclosporine, Fludarabine, Mycophenolate Mofetil, Bone Marrow Transplantation
September 8, 2008
1010
NCT00004404
Completed
Completed
Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes
Conditions: Sickle Cell Anemia
Intervention: Clotrimazole, Hydroxyurea
Conditions: Sickle Cell Anemia
Intervention: Clotrimazole, Hydroxyurea
March 24, 2015
1011
NCT01125163
Completed
Completed
Trial Comparing Iron Supplementation Versus Routine Iron Intake in Very Low Birth Weight Infants
Conditions: Iron Deficiency Anemia
Intervention: Iron Supplement, Multivitamin
Conditions: Iron Deficiency Anemia
Intervention: Iron Supplement, Multivitamin
July 10, 2018
1012
NCT01438372
Withdrawn
Withdrawn
IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD
Conditions: Iron Deficiency Anemia; Inflammatory Bowel Disease
Intervention: Intravenous Iron Sucrose, Oral Ferrous Sulfate
Conditions: Iron Deficiency Anemia; Inflammatory Bowel Disease
Intervention: Intravenous Iron Sucrose, Oral Ferrous Sulfate
January 4, 2014
1013
NCT00508131
Completed
Completed
Effectiveness of Iron-Fortified Milk on Iron Status and Anemia in Young Children in Mexico
Conditions: Anemia; Iron Deficiency; Stunting
Intervention: Whole Cows Milk
Conditions: Anemia; Iron Deficiency; Stunting
Intervention: Whole Cows Milk
July 26, 2007
1014
NCT02022891
Completed
Completed
Systematic Psychological and Medical Care for Children With SCD
Conditions: Anemia, Sickle Cell
Intervention: Systematic Psychological Care
Conditions: Anemia, Sickle Cell
Intervention: Systematic Psychological Care
August 5, 2014
1015
NCT00402480
Completed
Completed
Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow Velocity
Conditions: Stroke
Intervention: Hydroxyurea
Conditions: Stroke
Intervention: Hydroxyurea
June 17, 2013
1016
NCT02004808
Not yet recruiting
Not yet recruiting
Neutrophil Extracellular Traps and Sickle Cell Disease
Conditions: Sickle Cell Anemia
Conditions: Sickle Cell Anemia
December 3, 2013
1017
NCT03997903
Not yet recruiting
Not yet recruiting
Imatinib for Pain in Sickle Cell Anemia
Conditions: Sickle Cell Disease
Intervention: Imatinib Mesylate
Conditions: Sickle Cell Disease
Intervention: Imatinib Mesylate
June 25, 2019
1018
NCT03944733
Not yet recruiting
Not yet recruiting
Iron Status, Maternal Depressive Symptoms, and Mother-child Interactions
Conditions: Iron Deficiency Anemia
Intervention: Iron, Gelatin
Conditions: Iron Deficiency Anemia
Intervention: Iron, Gelatin
August 28, 2019
1019
NCT04074707
Not yet recruiting
Not yet recruiting
Defining a Dosing Regimen With Maximal Absorption for Oral Iron Supplementation During Pregnancy
Conditions: Iron Deficiency Anemia of Pregnancy
Intervention: Labeled Iron Solution (60mg And 120mg Ferrous Sulfate)
Conditions: Iron Deficiency Anemia of Pregnancy
Intervention: Labeled Iron Solution (60mg And 120mg Ferrous Sulfate)
August 27, 2019
1020
NCT03777514
Withdrawn
Withdrawn
Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical Patient
Conditions: IDA in the Post-bariatric Surgical Patient
Intervention: Ferumoxytol, Ferrous Sulfate, Oral Vitamin C, Intravenous Normal Saline
Conditions: IDA in the Post-bariatric Surgical Patient
Intervention: Ferumoxytol, Ferrous Sulfate, Oral Vitamin C, Intravenous Normal Saline
September 9, 2019
1021
NCT03541980
Recruiting
Recruiting
Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?
Conditions: Sickle Cell Anemia Crisis
Intervention: Acetaminophen, Normal Saline
Conditions: Sickle Cell Anemia Crisis
Intervention: Acetaminophen, Normal Saline
August 20, 2018
1022
NCT01783990
Unknown status
Unknown status
Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol
Conditions: Sickle Cell Anemia
Intervention: Hydroxyurea
Conditions: Sickle Cell Anemia
Intervention: Hydroxyurea
September 23, 2016
1023
NCT01817699
Terminated
Terminated
Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients
Conditions: Kidney Transplantation; Anemia; Vitamin D Deficiency; Renal Insufficiency, Chronic
Intervention: High Hb Target, Cholecalciferol
Conditions: Kidney Transplantation; Anemia; Vitamin D Deficiency; Renal Insufficiency, Chronic
Intervention: High Hb Target, Cholecalciferol
January 31, 2019
1024
NCT02481375
Completed
Completed
Is Iron Deficiency the Cause of Anemia Among Women in Cambodia?
Conditions: Anemia; Iron Deficiency; Hemoglobin Disorder; Infection; Inflammation
Intervention: Multiple Micronutrients, Iron, Placebo
Conditions: Anemia; Iron Deficiency; Hemoglobin Disorder; Infection; Inflammation
Intervention: Multiple Micronutrients, Iron, Placebo
April 30, 2019
1025
NCT01148745
Completed
Completed
Iron Indices and Intravenous Ferumoxytol: Time to Steady State
Conditions: Iron Deficiency Anemia
Intervention: Ferumoxytol
Conditions: Iron Deficiency Anemia
Intervention: Ferumoxytol
March 28, 2012
1026
NCT01716403
Terminated
Terminated
Telaprevir Exposure and Severe Anemia in HCV Infected Patients Treated by Tri-therapy
Conditions: C Hepatitis, Tri Therapy
Intervention: Diagnostic: Protocol Designed To Evaluate One Or More Interventions Aimed At Identifying A Disease Or Health Condition
Conditions: C Hepatitis, Tri Therapy
Intervention: Diagnostic: Protocol Designed To Evaluate One Or More Interventions Aimed At Identifying A Disease Or Health Condition
January 12, 2017
1027
NCT01522547
Completed
Completed
Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sickle Cell Disease
Conditions: Anemia, Sickle Cell
Intervention: Pomalidomide
Conditions: Anemia, Sickle Cell
Intervention: Pomalidomide
December 24, 2013
1028
NCT04053803
Enrolling by invitation
Enrolling by invitation
An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia
Conditions: Sickle Cell Disease
Intervention: IMR-687
Conditions: Sickle Cell Disease
Intervention: IMR-687
August 8, 2019
1029
NCT01151592
Withdrawn
Withdrawn
Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)
Conditions: Iron Deficiency Anemia
Intervention: Iron Sucrose
Conditions: Iron Deficiency Anemia
Intervention: Iron Sucrose
January 22, 2018
1030
NCT03606993
Recruiting
Recruiting
Iron Fish for Dominican Republic (DR) Infants
Conditions: Iron-deficiency; Iron Deficiency Anemia
Intervention: Lucky Iron Fish (TM) - An Iron Ingot That Is A Cooking Supplement
Conditions: Iron-deficiency; Iron Deficiency Anemia
Intervention: Lucky Iron Fish (TM) - An Iron Ingot That Is A Cooking Supplement
August 30, 2019
1031
NCT04109820
Not yet recruiting
Not yet recruiting
Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia
Conditions: Sickle Cell Disease
Intervention: MitoQ
Conditions: Sickle Cell Disease
Intervention: MitoQ
September 27, 2019
1032
NCT00094887
Completed
Completed
Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises
Conditions: Anemia, Sickle Cell
Intervention: Nitric Oxide, Placebo
Conditions: Anemia, Sickle Cell
Intervention: Nitric Oxide, Placebo
October 25, 2017
1033
NCT00005682
Completed
Completed
Aplastic Anemia Epidemiology: Incidence and Case-control
Conditions: Blood Disease; Anemia, Aplastic
Conditions: Blood Disease; Anemia, Aplastic
February 17, 2016
1034
NCT00551603
Withdrawn
Withdrawn
Anaemia Correction in Haemodialyzed Patients - Comparative Analysis of Two Erythropoietin Stimulating Agents Schedules
Conditions: Bio-Equivalency of 2 Treatment Schedules in HD Patients
Intervention: Switch (epoetinum Beta, Darbepoetinum), Continuation (darbepoetinum)
Conditions: Bio-Equivalency of 2 Treatment Schedules in HD Patients
Intervention: Switch (epoetinum Beta, Darbepoetinum), Continuation (darbepoetinum)
December 21, 2017
1035
NCT02943668
Recruiting
Recruiting
Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
Conditions: Anemia; Myelodysplastic Syndrome
Intervention: Deferasirox, Laboratory Biomarker Analysis
Conditions: Anemia; Myelodysplastic Syndrome
Intervention: Deferasirox, Laboratory Biomarker Analysis
October 7, 2019
1036
NCT03188445
Recruiting
Recruiting
Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.
Conditions: Iron Deficiency Anemia of Pregnancy
Intervention: Iron Isomaltoside 1000, Ferrous Fumarate With Ascorbic Acid
Conditions: Iron Deficiency Anemia of Pregnancy
Intervention: Iron Isomaltoside 1000, Ferrous Fumarate With Ascorbic Acid
December 17, 2018
1037
NCT01178099
Completed
Completed
An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults
Conditions: Anemia, Sickle Cell
Intervention: Prasugrel
Conditions: Anemia, Sickle Cell
Intervention: Prasugrel
January 12, 2012
1038
NCT03145896
Unknown status
Unknown status
The Correlation Between Anemia of Chronic Diseases, Hepcidin and Vitamin D in IBD Patients
Conditions: IBD
Intervention: Vitamin D
Conditions: IBD
Intervention: Vitamin D
May 8, 2017
1039
NCT01137721
Completed
Completed
State Of The Art Functional Imaging In Sickle Cell Disease
Conditions: Sickle Cell Anemia
Conditions: Sickle Cell Anemia
August 21, 2018
1040
NCT01626547
Completed
Completed
Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology
Conditions: Chemotherapy-induced Symptomatic Anaemia; Solid Tumours; Malignant Lymphomas; Multiple Myeloma
Conditions: Chemotherapy-induced Symptomatic Anaemia; Solid Tumours; Malignant Lymphomas; Multiple Myeloma
March 16, 2017
1041
NCT00001962
Terminated
Terminated
A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
Conditions: Aplastic Anemia; Pure Red Cell Aplasia; Diamond Blackfan Anemia
Intervention: Daclizumab
Conditions: Aplastic Anemia; Pure Red Cell Aplasia; Diamond Blackfan Anemia
Intervention: Daclizumab
April 28, 2015
1042
NCT03071497
Completed
Completed
Non-invasive Diagnostics of Iron Deficiency in Surgical Patients by Measuring Zinc Protoporphyrin-IX
Conditions: Iron-deficiency; Anemia; Iron Deficiency Anemia
Intervention: Non-invasive Analysis Of Zinc Protoporphyrin
Conditions: Iron-deficiency; Anemia; Iron Deficiency Anemia
Intervention: Non-invasive Analysis Of Zinc Protoporphyrin
July 14, 2018
1043
NCT00306267
Terminated
Terminated
A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy
Conditions: Anemia; Cancer; Epoetin Alfa
Intervention: Epoetin Alfa
Conditions: Anemia; Cancer; Epoetin Alfa
Intervention: Epoetin Alfa
May 17, 2011
1044
NCT00009581
Completed
Completed
Nitric Oxide to Improve Blood Flow in Sickle Cell Disease
Conditions: Sickle Cell Anemia
Intervention: L-NMMA, Acetylcholine
Conditions: Sickle Cell Anemia
Intervention: L-NMMA, Acetylcholine
March 3, 2008
1045
NCT01877837
Active, not recruiting
Active, not recruiting
Stem Cell Transplantation for Sickle Cell Anemia
Conditions: Sickle Cell Disease
Intervention: Alemtuzumab, Fludarabine, Melphalan, Stem Cells
Conditions: Sickle Cell Disease
Intervention: Alemtuzumab, Fludarabine, Melphalan, Stem Cells
August 5, 2019
1046
NCT00783627
Completed
Completed
Sickle Cell Disease and Endothelial Progenitor Cells (EPCs)
Conditions: Sickle Cell Anemia
Intervention: Angiography
Conditions: Sickle Cell Anemia
Intervention: Angiography
February 22, 2011
1047
NCT01693029
Completed
Completed
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Conditions: Anemia; Chronic Kidney Disease (CKD)
Intervention: HX575 Epoetin Alfa, US-licensed Epoetin Alfa
Conditions: Anemia; Chronic Kidney Disease (CKD)
Intervention: HX575 Epoetin Alfa, US-licensed Epoetin Alfa
June 1, 2017
1048
NCT00004797
Completed
Completed
Pilot Study of Fructose for Sickle Cell Crisis
Conditions: Sickle Cell Anemia
Intervention: Fructose, Placebo
Conditions: Sickle Cell Anemia
Intervention: Fructose, Placebo
June 23, 2005
1049
NCT00004408
Completed
Completed
Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease
Conditions: Sickle Cell Anemia
Intervention: Poloxamer 188
Conditions: Sickle Cell Anemia
Intervention: Poloxamer 188
March 5, 2012
1050
NCT01116479
Terminated
Terminated
Optimal Transfusion in Anaemic Cancer Patients Treated With Chemotherapy (HaemOPtimal)
Conditions: Cancer; Anaemia
Intervention: Blood Transfusion
Conditions: Cancer; Anaemia
Intervention: Blood Transfusion
November 3, 2014
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 … 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 Next Last
Last Updated
The last updated date is the most recent date when changes to a clinical trial were
submitted to ClinicalTrials.gov. There is often a delay of a few days before the
updated trial is available on the clinical trials website.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
First Received
The first received date is the date when the clinical trial was first submitted
to ClinicalTrials.gov. There is often a delay of a few days before the
trial is available on the clinical trials website.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Safety Issue
If selected, restricts search results to those studies which have
an outcome measure designated as a safety issue. Note that this is a
poor estimate of the safety of a treatment or intervention, but it is
all we have now.
Funded By
Studies are supported by one or more organizations called sponsors.
Support includes contributions of facilities, expertise, and/or financial resources.
All sponsors in the database have been assigned one of the following organization types:
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
Study Phase
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Age Group
Studies may be designed for participants of particular ages:
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Gender
Searches can be restricted to studies which accept female or male participants.
Location Terms
If you are interested in a specific city (such as Los Angeles) or facility
name (such as the Mayo Clinic), enter it as a location term. Not all studies
include this level of detail, but if they do, this will find them.
Countries and States
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state.
Study IDs
Each trial is assigned one or more identification numbers by the institute, agency,
or organization sponsoring the trial. In addition, clinical trials assigns a
unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit.
Use this box to search for a trial by NCT identifier or any other study
identification numbers.
Examples:
Examples:
NCT00001789
97-h-0197
ia0006
actg 076
97-h-0197
ia0006
actg 076
Sponsor (Lead)
Use this box to specify the name of an institute, organization, or company that is
conducting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators
Use this box to specify institutes, organizations, or companies that are
conducting or otherwise supporting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Outcome Measures
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Outcome measures are used to evaluate trial results. For example, an obesity treatment
might be evaluated by a measure of weight loss after 6 months. Measures can also be used
to quantify side effects, such as number of myocardial infarctions,
number of patients with heart arrhythmia, number of suicides, etc.
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Interventions
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Conditions
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Study Type
There are three types of studies available in ClinicalTrials.gov:
There are three types of studies available in ClinicalTrials.gov:
Interventional:
Observational:
Expanded Access:
Studies where individuals are assigned to receive specific interventions.
Participants may receive diagnostic, therapeutic or other types of interventions.
Assignment of the intervention may or may not be random.
Individuals are tracked and biomedical and/or health outcomes are assessed.
Observational:
Studies without an intervention.
Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals.
Participants may receive diagnostic, therapeutic, or other interventions, but the investigator
does not assign specific interventions to the participants of the study.
Expanded Access:
Records describing the procedure for obtaining an experimental drug or device for patients who
are failing on currently available treatments for their condition and also are unable to
participate in ongoing clinical trials. Expanded Access records are used to register all
types of non-protocol access to experimental treatments, including protocol exception,
single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.
Study Results
Searches can be restricted to studies with or without results.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Recruitment Status
Also known as Enrollment Status.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Search Terms
Use this box to specify general search terms found anywhere in the trial record.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help for Searching clinical trials
Help Topics:
Basic Search:
On the Basic Search page, enter a word or word(s) that you want to use to find studies.
These may include diseases, interventions, and/or locations.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
Many searches are a single term and can be performed with a few words in the
search box. But, sometimes you need more control. Click on the Advanced Search tab
(if starting a new search) or Refine Search tab (if modifying an existing search)
to show additional search fields.
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
Sponsor (Lead):
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Performs a general search in all sections of the study record, including title,
description, conditions, interventions, locations, etc. Terms in this field are
searched the same as Basic Search.
Recruitment:
Limits search results to studies that are open or closed. New volunteers may be
able to participate in open studies, but not closed studies.
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Study Results:Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Limits search results based on whether the study has results or not:
Study Type:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov.
Only a few studies have results available.Studies With Results, or
Studies Without Results
Limits search results to any of the following study types:
Conditions:
Interventional,
Observational, or
Expanded Access
Observational, or
Expanded Access
Performs a search on fields describing the diseases or conditions being studied.
Interventions:
Performs a search on fields listing the drugs or interventions being studied.
Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.
Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
Performs a search on the sponsor field of a study.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Performs a search on fields listing ID numbers.
Country/State:
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state (e.g., United States, Alabama).
Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic).
Not all studies include this level of detail, but if they do, this will find them.
Gender:
Limits search results to those studies that accept female or male participants.
Age Group:
Limits search results to those studies that include at least one of the specified age
ranges. More than one age group can be selected.
Phase:
Limits search results to studies that are labeled with at least one of the specified
phases. More than one Phase can be selected.
Funded By:
Limits search results to studies that have at least one sponsor of the specified types.
More than one sponsor type can be selected.
Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.
First Received:
Limits search results to studies that were received by clinical trials within a
specified date range. The "From" or "To" field can be left blank.
Last Updated:
Limits search results to studies that were modified within a
specified date range. The "From" or "To" field can be left blank.
Refine Search:
Searches display a list of studies found (List Results tab). If you are not content with
the search results, click on the Refine Search tab at the top of the list to modify your
search.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
When you are done making changes, click Search to display the new results.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.